Commentary
COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic

https://doi.org/10.1016/j.cmi.2022.10.033Get rights and content

Keywords

Convalescent plasma
COVID-19 convalescent plasma
COVID-19 pandemic
COVID-19 symptom duration
High titer
Immunosuppressed patients
SARS-CoV-2 antibodies
Serum therapy

Cited by (0)

View Abstract
© 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.